Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

NCT05554419 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

184

Enrollment

NIH

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Acute Myeloid Leukemia Arising From Previous Myeloproliferative Neoplasm
Acute Myeloid Leukemia Post Cytotoxic Therapy
Secondary Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cytarabine
PROCEDURE: Echocardiography Test
DRUG: Liposome-encapsulated Daunorubicin-Cytarabine
PROCEDURE: Multigated Acquisition Scan
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)